These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

182 related items for PubMed ID: 7545317

  • 1. One month follow-up of haemostatic variables in patients undergoing aortocoronary bypass surgery. Effect of aprotinin.
    Mannucci L, Gerometta PS, Mussoni L, Antona C, Parolari A, Salvi L, Biglioli P, Tremoli E.
    Thromb Haemost; 1995 Mar; 73(3):356-61. PubMed ID: 7545317
    [Abstract] [Full Text] [Related]

  • 2. Postoperative hemostasis and fibrinolysis in patients undergoing cardiopulmonary bypass with or without aprotinin therapy.
    Lu H, Du Buit C, Soria J, Touchot B, Chollet B, Commin PL, Conseiller C, Echter E, Soria C.
    Thromb Haemost; 1994 Sep; 72(3):438-43. PubMed ID: 7531877
    [Abstract] [Full Text] [Related]

  • 3. Coagulation and fibrinolytic markers in a two-month follow-up of coronary bypass surgery.
    Parolari A, Colli S, Mussoni L, Eligini S, Naliato M, Wang X, Gandini S, Tremoli E, Biglioli P, Alamanni F.
    J Thorac Cardiovasc Surg; 2003 Feb; 125(2):336-43. PubMed ID: 12579103
    [Abstract] [Full Text] [Related]

  • 4. Alterations of haemostatic and fibrinolytic markers in adult patients with growth hormone deficiency and with acromegaly.
    Sartorio A, Cattaneo M, Bucciarelli P, Bottasso B, Porretti S, Epaminonda P, Faglia G, Arosio M.
    Exp Clin Endocrinol Diabetes; 2000 Feb; 108(7):486-92. PubMed ID: 11083070
    [Abstract] [Full Text] [Related]

  • 5. The kinetics of plasmin inhibition by aprotinin in vivo.
    Kang HM, Kalnoski MH, Frederick M, Chandler WL.
    Thromb Res; 2005 Feb; 115(4):327-40. PubMed ID: 15668193
    [Abstract] [Full Text] [Related]

  • 6. Thrombin production, inactivation and expression during open heart surgery measured by assays for activation fragments including a new ELISA for prothrombin fragment F1 + 2.
    Boisclair MD, Lane DA, Philippou H, Sheikh S, Hunt B.
    Thromb Haemost; 1993 Aug 02; 70(2):253-8. PubMed ID: 8236130
    [Abstract] [Full Text] [Related]

  • 7. Haemostatic and inflammatory biomarkers in advanced chronic heart failure: role of oral anticoagulants and successful heart transplantation.
    Cugno M, Mari D, Meroni PL, Gronda E, Vicari F, Frigerio M, Coppola R, Bottasso B, Borghi MO, Gregorini L.
    Br J Haematol; 2004 Jul 02; 126(1):85-92. PubMed ID: 15198737
    [Abstract] [Full Text] [Related]

  • 8. Hemostatic activation during cardiopulmonary bypass with different aprotinin dosages in pediatric patients having cardiac operations.
    Dietrich W, Mössinger H, Spannagl M, Jochum M, Wendt P, Barankay A, Meisner H, Richter JA.
    J Thorac Cardiovasc Surg; 1993 Apr 02; 105(4):712-20. PubMed ID: 7682267
    [Abstract] [Full Text] [Related]

  • 9. Cardiopulmonary bypass parameters and hemostatic response to cardiopulmonary bypass in infants versus children.
    Eisses MJ, Chandler WL.
    J Cardiothorac Vasc Anesth; 2008 Feb 02; 22(1):53-9. PubMed ID: 18249331
    [Abstract] [Full Text] [Related]

  • 10. Coagulation and fibrinolysis system in aortic surgery under deep hypothermic circulatory arrest with aprotinin: the importance of adequate heparinization.
    Okita Y, Takamoto S, Ando M, Morota T, Yamaki F, Matsukawa R, Kawashima Y.
    Circulation; 1997 Nov 04; 96(9 Suppl):II-376-81. PubMed ID: 9386127
    [Abstract] [Full Text] [Related]

  • 11. Changes in hemostasis during pediatric heart surgery: impact of a biocompatible heparin-coated perfusion system.
    Jensen E, Andréasson S, Bengtsson A, Berggren H, Ekroth R, Larsson LE, Ouchterlony J.
    Ann Thorac Surg; 2004 Mar 04; 77(3):962-7. PubMed ID: 14992907
    [Abstract] [Full Text] [Related]

  • 12. Effect of intraoperative aprotinin administration on postoperative bleeding in patients undergoing cardiopulmonary bypass operation.
    Havel M, Teufelsbauer H, Knöbl P, Dalmatiner R, Jaksch P, Zwölfer W, Müller M, Vukovich T.
    J Thorac Cardiovasc Surg; 1991 Jun 04; 101(6):968-72. PubMed ID: 1710009
    [Abstract] [Full Text] [Related]

  • 13. The effects of aprotinin and steroids on generation of cytokines during coronary artery surgery.
    Türköz A, Ciğli A, But K, Sezgin N, Türköz R, Gülcan O, Ersoy MO.
    J Cardiothorac Vasc Anesth; 2001 Oct 04; 15(5):603-10. PubMed ID: 11688002
    [Abstract] [Full Text] [Related]

  • 14. Influence of long term oral anticoagulants upon prothrombin fragment 1 + 2, thrombin-antithrombin III complex and D-Dimer levels in patients affected by proximal deep vein thrombosis.
    Elias A, Bonfils S, Daoud-Elias M, Gauthier B, Sié P, Boccalon H, Boneu B.
    Thromb Haemost; 1993 Apr 01; 69(4):302-5. PubMed ID: 8497840
    [Abstract] [Full Text] [Related]

  • 15. Effects of high-dose aprotinin on blood loss, platelet function, fibrinolysis, complement, and renal function after cardiopulmonary bypass.
    Blauhut B, Gross C, Necek S, Doran JE, Späth P, Lundsgaard-Hansen P.
    J Thorac Cardiovasc Surg; 1991 Jun 01; 101(6):958-67. PubMed ID: 1710008
    [Abstract] [Full Text] [Related]

  • 16. Early markers of blood coagulation and fibrinolysis activation in Argentine hemorrhagic fever.
    Heller MV, Marta RF, Sturk A, Maiztegui JI, Hack CE, Cate JW, Molinas FC.
    Thromb Haemost; 1995 Mar 01; 73(3):368-73. PubMed ID: 7667817
    [Abstract] [Full Text] [Related]

  • 17. Thrombin generation during cardiac surgery: is heparin the ideal anticoagulant?
    Brister SJ, Ofosu FA, Buchanan MR.
    Thromb Haemost; 1993 Aug 02; 70(2):259-62. PubMed ID: 8236131
    [Abstract] [Full Text] [Related]

  • 18. Low doses of aprotinin in aortocoronary bypass surgery--advantages and disadvantages.
    Golański R, Golański J, Chizyński K, Iwaszkiewicz A, Zasłonka J, Pietrucha T, Chrul S, Watała C.
    Med Sci Monit; 2000 Aug 02; 6(4):722-8. PubMed ID: 11208399
    [Abstract] [Full Text] [Related]

  • 19. Effect of low-dose aprotinin on coagulation and fibrinolysis in cardiopulmonary bypass.
    Kawasuji M, Ueyama K, Sakakibara N, Tedoriya T, Matsunaga Y, Misaki T, Watanabe Y.
    Ann Thorac Surg; 1993 May 02; 55(5):1205-9. PubMed ID: 7684219
    [Abstract] [Full Text] [Related]

  • 20. Protection of single-chain urokinase-type plasminogen activator (scu-PA) in aprotinin treated cardiac surgical patients undergoing cardiopulmonary bypass.
    Spannagl M, Dooijewaard G, Dietrich W, Kluft C.
    Thromb Haemost; 1995 May 02; 73(5):825-8. PubMed ID: 7482410
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.